1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Indirect Immunofluorescence
        1.2.3 Enzyme-linked Immunosorbent Assay (ELISA)
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-nuclear Antibody (ANA) Testing Market Perspective (2017-2028)
    2.2 Anti-nuclear Antibody (ANA) Testing Growth Trends by Region
        2.2.1 Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anti-nuclear Antibody (ANA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Anti-nuclear Antibody (ANA) Testing Market Dynamics
        2.3.1 Anti-nuclear Antibody (ANA) Testing Industry Trends
        2.3.2 Anti-nuclear Antibody (ANA) Testing Market Drivers
        2.3.3 Anti-nuclear Antibody (ANA) Testing Market Challenges
        2.3.4 Anti-nuclear Antibody (ANA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue
        3.1.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue
    3.4 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio
        3.4.1 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-nuclear Antibody (ANA) Testing Revenue in 2021
    3.5 Anti-nuclear Antibody (ANA) Testing Key Players Head office and Area Served
    3.6 Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
    3.7 Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Type
    4.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2023-2028)
5 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Application
    5.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
    6.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type
        6.2.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022)
        6.2.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028)
        6.2.3 North America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028)
    6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application
        6.3.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022)
        6.3.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028)
        6.3.3 North America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028)
    6.4 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country
        6.4.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
        6.4.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
    7.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type
        7.2.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028)
    7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application
        7.3.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028)
    7.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country
        7.4.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type
        8.2.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application
        8.3.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region
        8.4.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
    9.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type
        9.2.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028)
    9.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application
        9.3.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028)
    9.4 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country
        9.4.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type
        10.2.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application
        10.3.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country
        10.4.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abcam
        11.1.1 Abcam Company Details
        11.1.2 Abcam Business Overview
        11.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction
        11.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.1.5 Abcam Recent Developments
    11.2 Antibodies
        11.2.1 Antibodies Company Details
        11.2.2 Antibodies Business Overview
        11.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction
        11.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.2.5 Antibodies Recent Developments
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Company Details
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction
        11.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.3.5 Bio-Rad Laboratories Recent Developments
    11.4 Alere
        11.4.1 Alere Company Details
        11.4.2 Alere Business Overview
        11.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction
        11.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.4.5 Alere Recent Developments
    11.5 Erba Diagnostics
        11.5.1 Erba Diagnostics Company Details
        11.5.2 Erba Diagnostics Business Overview
        11.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction
        11.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.5.5 Erba Diagnostics Recent Developments
    11.6 MBL International
        11.6.1 MBL International Company Details
        11.6.2 MBL International Business Overview
        11.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction
        11.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.6.5 MBL International Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction
        11.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Indur Services
        11.8.1 Indur Services Company Details
        11.8.2 Indur Services Business Overview
        11.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction
        11.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.8.5 Indur Services Recent Developments
    11.9 Trinity Biotech
        11.9.1 Trinity Biotech Company Details
        11.9.2 Trinity Biotech Business Overview
        11.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction
        11.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.9.5 Trinity Biotech Recent Developments
    11.10 Thermo Fisher Scientific
        11.10.1 Thermo Fisher Scientific Company Details
        11.10.2 Thermo Fisher Scientific Business Overview
        11.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction
        11.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.10.5 Thermo Fisher Scientific Recent Developments
    11.11 Zeus Scientific
        11.11.1 Zeus Scientific Company Details
        11.11.2 Zeus Scientific Business Overview
        11.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction
        11.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
        11.11.5 Zeus Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Indirect Immunofluorescence
    Table 3. Key Players of Enzyme-linked Immunosorbent Assay (ELISA)
    Table 4. Key Players of Other
    Table 5. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region (2017-2022)
    Table 9. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region (2023-2028)
    Table 11. Anti-nuclear Antibody (ANA) Testing Market Trends
    Table 12. Anti-nuclear Antibody (ANA) Testing Market Drivers
    Table 13. Anti-nuclear Antibody (ANA) Testing Market Challenges
    Table 14. Anti-nuclear Antibody (ANA) Testing Market Restraints
    Table 15. Global Anti-nuclear Antibody (ANA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Players (2017-2022)
    Table 17. Global Top Anti-nuclear Antibody (ANA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2021)
    Table 18. Ranking of Global Top Anti-nuclear Antibody (ANA) Testing Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
    Table 22. Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2017-2022)
    Table 26. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2023-2028)
    Table 28. Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Application (2017-2022)
    Table 30. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Application (2023-2028)
    Table 32. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Abcam Company Details
    Table 63. Abcam Business Overview
    Table 64. Abcam Anti-nuclear Antibody (ANA) Testing Product
    Table 65. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 66. Abcam Recent Developments
    Table 67. Antibodies Company Details
    Table 68. Antibodies Business Overview
    Table 69. Antibodies Anti-nuclear Antibody (ANA) Testing Product
    Table 70. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 71. Antibodies Recent Developments
    Table 72. Bio-Rad Laboratories Company Details
    Table 73. Bio-Rad Laboratories Business Overview
    Table 74. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product
    Table 75. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 76. Bio-Rad Laboratories Recent Developments
    Table 77. Alere Company Details
    Table 78. Alere Business Overview
    Table 79. Alere Anti-nuclear Antibody (ANA) Testing Product
    Table 80. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 81. Alere Recent Developments
    Table 82. Erba Diagnostics Company Details
    Table 83. Erba Diagnostics Business Overview
    Table 84. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product
    Table 85. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 86. Erba Diagnostics Recent Developments
    Table 87. MBL International Company Details
    Table 88. MBL International Business Overview
    Table 89. MBL International Anti-nuclear Antibody (ANA) Testing Product
    Table 90. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 91. MBL International Recent Developments
    Table 92. Merck Company Details
    Table 93. Merck Business Overview
    Table 94. Merck Anti-nuclear Antibody (ANA) Testing Product
    Table 95. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 96. Merck Recent Developments
    Table 97. Indur Services Company Details
    Table 98. Indur Services Business Overview
    Table 99. Indur Services Anti-nuclear Antibody (ANA) Testing Product
    Table 100. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 101. Indur Services Recent Developments
    Table 102. Trinity Biotech Company Details
    Table 103. Trinity Biotech Business Overview
    Table 104. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product
    Table 105. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 106. Trinity Biotech Recent Developments
    Table 107. Thermo Fisher Scientific Company Details
    Table 108. Thermo Fisher Scientific Business Overview
    Table 109. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product
    Table 110. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 111. Thermo Fisher Scientific Recent Developments
    Table 112. Zeus Scientific Company Details
    Table 113. Zeus Scientific Business Overview
    Table 114. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product
    Table 115. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
    Table 116. Zeus Scientific Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. Indirect Immunofluorescence Features
    Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Features
    Figure 4. Other Features
    Figure 5. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Other Case Studies
    Figure 9. Anti-nuclear Antibody (ANA) Testing Report Years Considered
    Figure 10. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region: 2021 VS 2028
    Figure 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players in 2021
    Figure 14. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue in 2021
    Figure 16. North America Anti-nuclear Antibody (ANA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Type (2017-2028)
    Figure 18. North America Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Application (2017-2028)
    Figure 19. North America Anti-nuclear Antibody (ANA) Testing Market Size Share by Country (2017-2028)
    Figure 20. United States Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Anti-nuclear Antibody (ANA) Testing Market Size Share by Country (2017-2028)
    Figure 26. Germany Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Anti-nuclear Antibody (ANA) Testing Market Size Share by Region (2017-2028)
    Figure 36. China Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Anti-nuclear Antibody (ANA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Anti-nuclear Antibody (ANA) Testing Market Size Share by Country (2017-2028)
    Figure 46. Mexico Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size Share by Country (2017-2028)
    Figure 52. Turkey Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 56. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 58. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 59. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 60. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 61. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 62. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 63. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 65. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed